Vitalhub Corp. (TSE:VHI – Get Free Report) was down 2.6% during mid-day trading on Thursday . The stock traded as low as C$7.20 and last traded at C$7.23. 187,463 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 357,574 shares. The stock had previously closed at C$7.42.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on the stock. National Bank Financial dropped their price objective on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating for the company in a research note on Wednesday, May 27th. Raymond James Financial reduced their target price on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. One research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of C$13.14.
Read Our Latest Research Report on Vitalhub
Vitalhub Stock Performance
Vitalhub (TSE:VHI – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported C$0.04 earnings per share (EPS) for the quarter. The company had revenue of C$31.91 million for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. Equities analysts expect that Vitalhub Corp. will post 0.2296467 EPS for the current fiscal year.
Insider Activity
In related news, Director Steve Garrington sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of C$7.17, for a total transaction of C$71,700.00. Following the transaction, the director owned 50,000 shares of the company’s stock, valued at approximately C$358,500. This represents a 16.67% decrease in their ownership of the stock. Insiders own 18.57% of the company’s stock.
Vitalhub Company Profile
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also
- Five stocks we like better than Vitalhub
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
